mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.02 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |